Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening
- Conditions
- Cervical CancerBreast Cancer
- Registration Number
- NCT01910350
- Lead Sponsor
- Michigan State University
- Brief Summary
1) To determine if the Kin KeeperSM Cancer Prevention Intervention increases first time and appropriately timed breast cancer screening rates among Black, Latina and Arab women; 2) To determine if the Kin KeeperSM Cancer Prevention Intervention increase first time and appropriately time cervical cancer screening rates among Black, Latina and Arab women; 3) To measure functional cancer literacy over time at the individual and familial level and 4) Assess rates of healthcare utilization cost among women in the Kin KeeperSM intervention and control-comparison groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 516
- Participants:self-identified as Black Latina and Arab women ho can recruit at least two bloodline female family members (mother daughter sister, etc.; can accommodate two in-home visits by a community health worker; and 21-70 years of age.
- are not self-identified as Black, Latina, or Arab; do not have direct bloodline relatives; and are younger than 21 or older than 70 years of age.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method First time AND appropriately timed, clinical breast exam, mammogram, pap test Baseline through 36 months. Participants will complete measures every 6 months (baseline, 12 mo., 18 mo., 24 mo., 30 mo. \& 36 mo.)to measure increases in screening rates for experimental vs. control group.
- Secondary Outcome Measures
Name Time Method Increased Breast and Cervical Cancer Literacy rates. Baseline-36 months. Do participants have a higher breast and cervical cancer literacy rates post intervention and over 36 months than control group as well as better retention?
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Michigan State University
🇺🇸East Lansing, Michigan, United States
Michigan State University🇺🇸East Lansing, Michigan, United States